--- title: Innovation Vault - Blog (2) description: (2) --- [CALL: 631-467-8686](tel:631-467-8686) [CALL ![](https://blog.midipd.com/hubfs/MIDI_April_2020_Theme/Images/call.png)](tel:631-467-8686) [EMAIL ![](https://blog.midipd.com/hubfs/MIDI_April_2020_Theme/Images/email.png)](mailto:innovation@midipd.com) [![MIDI](https://blog.midipd.com/hs-fs/hubfs/raw_assets/public/MIDI_April_2020_Theme/images/logo.png?width=200&height=2048&name=logo.png "MIDI")](https://www.midipd.com/) - [About MIDI](https://www.midipd.com/about.php) - [Our Process](https://www.midipd.com/process.php) - [Services](https://www.midipd.com/process.php) - [Case Studies](https://www.midipd.com/gallery.php) - [Healthcare Strategy](https://www.midipd.com/healthcare.php) - [Innovation Vault](https://info.midipd.com/podcast) - [News](https://www.midipd.com/news/) - [Contact](https://www.midipd.com/contact.php) - [About MIDI](https://www.midipd.com/about.php) - [About MIDI](https://www.midipd.com/about.php) - [Product Experience](https://www.midipd.com/about_product.php) - [Interaction/Environment](https://www.midipd.com/about_interactive.php) - [Development Inputs](https://www.midipd.com/about_development.php) - [Value-Added MFG and Industry Partner Network](https://www.midipd.com/go-china.php) - [Our Process](https://www.midipd.com/process.php) - [Process Overview](https://www.midipd.com/process.php) - [DevelopmentDNA Steps](https://www.midipd.com/process_development.php) - [Regulatory Compliance](https://www.midipd.com/process_regulatory.php) - [Services](https://www.midipd.com/process.php) - [Research (Discover/Uncover)](https://www.midipd.com/services.php) - [Strategic Product Planning](https://www.midipd.com/services_strategic.php) - [Technology & IP Development](https://www.midipd.com/services_technology.php) - [Regulatory & Certifications](https://www.midipd.com/services_regulatory.php) - [Industrial Design/Innovation](https://www.midipd.com/services_industrial.php) - [Usability & Ergonomics](https://www.midipd.com/services_usability.php) - [Mechanical/MFG Engineering](https://www.midipd.com/services_mechanical.php) - [Engineering Analysis](https://www.midipd.com/services_engineering.php) - [Computer Aided Design](https://www.midipd.com/services_computer.php) - [Electrical Engineering](https://www.midipd.com/services_electrical.php) - [Interaction Design/GUI](https://www.midipd.com/services_interaction.php) - [Software Development](https://www.midipd.com/services_software.php) - [Rapid Prototyping](https://www.midipd.com/services_rapid.php) - [Manufacturing Liaison](https://www.midipd.com/services_manufacturing.php) - [Case Studies](https://www.midipd.com/gallery.php) - [Healthcare Strategy](https://www.midipd.com/healthcare.php) - [The Deep Dive: DevelopmentDNA](https://www.midipd.com/healthcare.php) - [Regulatory & Certification](https://www.midipd.com/healthcare_regulatory.php) - [Meaningful Relationships](https://www.midipd.com/healthcare_meaningful.php) - [Designing Globally](https://www.midipd.com/healthcare_designing.php) - [Environmental Field Context](https://www.midipd.com/healthcare_environmental.php) - [Surgeon to Patient](https://www.midipd.com/healthcare_surgeon.php) - [Optimize: Time, Money, Reliability](https://www.midipd.com/healthcare_optimize.php) - [Innovation Vault](https://info.midipd.com/podcast) - [Podcast](https://info.midipd.com/podcast) - [Blog](https://blog.midipd.com/blog) - [White Papers](https://info.midipd.com/white-papers) - [News](http://midipd.com/news/) - [News](http://midipd.com/news/) - [Awards](https://www.midipd.com/contact_awards.php) - [Contact](https://www.midipd.com/contact.php) - [Contact Us](https://www.midipd.com/contact.php) - [Client Zone](https://www.midipd.com/contact_client.php) - [Podcast](https://info.midipd.com/podcast) - [Blog](https://blog.midipd.com/blog) - [White Papers](https://info.midipd.com/white-papers) [Closed System Automation in a Point-of-Care Approach for CAR T-cell Fabrication](https://blog.midipd.com/blog/closed-system-automation-in-a-point-of-care-approach-for-car-t-cell-fabrication) *October 11th, 2023* [![Closed System Automation in a Point-of-Care Approach for CAR T-cell Fabrication](https://blog.midipd.com/hs-fs/hubfs/CAR%20T-cell%20Ep%205%20square%20(Twitter%20Post).png?width=767&name=CAR%20T-cell%20Ep%205%20square%20(Twitter%20Post).png)](https://blog.midipd.com/blog/closed-system-automation-in-a-point-of-care-approach-for-car-t-cell-fabrication) While cancer research has produced many advancements in the modern age, CAR T-cell therapy is one of the most impressive and promising. With the ability to target cancerous cells while leaving those... Click Image to Read More [Democratization via Manufacturing: Increasing CAR T-cell Accessibility by Shifting from a Centralized to Point-of-Care Approach](https://blog.midipd.com/blog/democratization-via-manufacturing-increasing-car-t-cell-accessibility-by-shifting-from-a-centralized-to-point-of-care-approach) *October 3rd, 2023* [![Democratization via Manufacturing: Increasing CAR T-cell Accessibility by Shifting from a Centralized to Point-of-Care Approach](https://blog.midipd.com/hs-fs/hubfs/CAR%20T-cell%20Ep%204%20square%20(Twitter%20Post)%20(1).png?width=767&name=CAR%20T-cell%20Ep%204%20square%20(Twitter%20Post)%20(1).png)](https://blog.midipd.com/blog/democratization-via-manufacturing-increasing-car-t-cell-accessibility-by-shifting-from-a-centralized-to-point-of-care-approach) With the unprecedented ability to destroy cancer while leaving healthy cells intact, CAR T-cell therapy is a groundbreaking treatment with the potential to usher the next generation of cancer-related... Click Image to Read More [Targeting Complex Cancers with CAR T-cell Therapy: Efficacy & Innovation](https://blog.midipd.com/blog/targeting-complex-cancers-with-car-t-cell-therapy-efficacy-innovation) *September 18th, 2023* [![Targeting Complex Cancers with CAR T-cell Therapy: Efficacy & Innovation](https://blog.midipd.com/hs-fs/hubfs/CAR%20T-cell%20Ep%203%20square%20(Twitter%20Post)%20(1).png?width=767&name=CAR%20T-cell%20Ep%203%20square%20(Twitter%20Post)%20(1).png)](https://blog.midipd.com/blog/targeting-complex-cancers-with-car-t-cell-therapy-efficacy-innovation) Although great strides have been made towards developing safer and more effective treatments for cancers of all types in the past few decades, the fact remains, some forms of this complex disease are... Click Image to Read More [Next-Generation CAR T-cell Therapy: Production & Format Types](https://blog.midipd.com/blog/next-generation-car-t-cell-therapy-production-format-types) *September 5th, 2023* [![Next-Generation CAR T-cell Therapy: Production & Format Types](https://blog.midipd.com/hs-fs/hubfs/CAR%20T-cell%20Ep%202%20square%20(Twitter%20Post).png?width=767&name=CAR%20T-cell%20Ep%202%20square%20(Twitter%20Post).png)](https://blog.midipd.com/blog/next-generation-car-t-cell-therapy-production-format-types) One of the most promising and rapidly evolving fields in modern medicine, CAR T-cell therapy is a relatively new cancer treatment with the potential to transform management of one of our most... Click Image to Read More [Ushering a New Era of Cancer Treatment with Democratization of CAR T-cell Therapy](https://blog.midipd.com/blog/the-beginnings-of-healthcares-next-iteration-innovations-in-rapid-diagnostics-post-pandemic-and-beyond-0-0-0) *August 21st, 2023* [![Ushering a New Era of Cancer Treatment with Democratization of CAR T-cell Therapy](https://blog.midipd.com/hs-fs/hubfs/CAR%20T-cell%20Ep%201%20square%20(Twitter%20Post).png?width=767&name=CAR%20T-cell%20Ep%201%20square%20(Twitter%20Post).png)](https://blog.midipd.com/blog/the-beginnings-of-healthcares-next-iteration-innovations-in-rapid-diagnostics-post-pandemic-and-beyond-0-0-0) Today's common cancer treatments are notoriously intense and physically taxing, with varying effectiveness. Fortunately, advancements in research and technology have made possible a new treatment... Click Image to Read More [Prev](https://blog.midipd.com/blog/page/1) [1](https://blog.midipd.com/blog/page/1) [2](https://blog.midipd.com/blog/page/2) [3](https://blog.midipd.com/blog/page/3) [4](https://blog.midipd.com/blog/page/4) [5](https://blog.midipd.com/blog/page/5) [Next](https://blog.midipd.com/blog/page/3) [![Facebook](https://blog.midipd.com/hs-fs/hubfs/MIDI_April_2020_Theme/Images/facebook_16.png?width=16&height=16&name=facebook_16.png)](http://www.facebook.com/pages/MIDI-Product-Development/172749396109979?ref=ts) [![Youtube](https://blog.midipd.com/hs-fs/hubfs/MIDI_April_2020_Theme/Images/youtube_16.png?width=16&height=16&name=youtube_16.png)](http://www.youtube.com/user/MIDImedical) [![Twitter](https://blog.midipd.com/hs-fs/hubfs/MIDI_April_2020_Theme/Images/twitter_16.png?width=16&height=16&name=twitter_16.png)](http://twitter.com/#!/MIDI_Medical) This site is protected by copyright and trademark laws under U.S. and International law. All rights reserved. © 2026 MIDI [Privacy Policy](https://www.midipd.com/privacy.php) | [T & C's](https://www.midipd.com/terms.php)